Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs Nov. 10, 2021
synTac platform delivers primary and costimulatory signals to activate virus-specific immune T cells Nov. 10, 2021
Massachusetts General Hospital to conduct preclinical trial of Angany's BP/AH-01 for peanut allergy Nov. 10, 2021
RSS